About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,591 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,591 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4941-4960 of 6,591 trials

UnknownMechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell LymphomaThis is a retrospective observational study of the therapeutic mechanism and resistance mechanism of the treatment of Selinexor combined with lenalidomide and rituximab in diffuse…NCT05923879·Shanghai UnknownStudy Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCLThis is a single-arm, open-label phase 2 study of iR2 in the treatment of unfit and elderly patients with untreated diffuse large B-cell lymphoma。NCT03949062·Shanghai, Shanghai Municipality TerminatedA Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)This is an open-label, randomized, Phase 3, multicenter trial, which has been designed to compare the efficacy and safety of T-Guard to ruxolitinib in patients with Grade III or…NCT04934670·Birmingham, Alabama and 47 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedA Study of ICP-022 in Patients With R/R DLBCLIt is a phase II, multicenter, open-label study is to evaluate the safety, efficacy and pharmacokinetics of a novel BTK inhibitor, ICP-022, in approximately 85 subjects with R/R…NCT04438005·Beijing, Beijing Municipality and 6 others

CompletedHigh Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic TransplantPatients are recruited at diagnosis or at relapse of ATLL-HR in French Caribbean islands and Guyana. They all receive Zidovudine and Pegylated Interferon (ZPI).NCT01941680·Pointe-à-Pitre and 1 other

CompletedOblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00070083·Stanford, California and 3 others

TerminatedLenalidomide Maintenance Post-debulking in Advanced CTCLRATIONALE: Observation is watching a patient's condition but not giving treatment unless symptoms appear or change.NCT01098656·Graz and 21 others

RecruitingTesting the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaThis phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or astrocytoma that has…NCT06860594·Duarte, California and 42 others

CompletedSWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaRATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and…NCT00900484·Anchorage, Alaska and 190 others

CompletedDiagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical CarcinomaThis is a prospective diagnostic performance study which compares three new imaging methods with the current standard imaging method for the diagnosis of metastatic lymph nodes.NCT01836484·Birmingham and 6 others

Active not recruitingNeo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine CancerThe goal of this clinical trial is to establish the fraction of patients that achieve a major pathological response (MPR) after 9 cycles of pembrolizumab, with the ultimate aim of…NCT06180733·Groningen, Provincie Groningen

CompletedVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesThis pilot phase II trial studies how well giving vorinostat, tacrolimus, and methotrexate works in preventing graft-versus-host disease (GVHD) after stem cell transplant in…NCT01789255·Ann Arbor, Michigan

CompletedGanciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusRATIONALE: The Epstein Barr virus can cause cancer and lymphoproliferative disorders. Ganciclovir is an antiviral drug that acts against the Epstein Barr virus.NCT00006340·Indianapolis, Indiana and 5 others

TerminatedPARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)Trial assessing atezolizumab (anti-PD-L1) as treatment option for patients with mycosis fungoides/sezary syndrome having progressed under or after previous therapy For this…NCT03357224·Madrid and 1 other

CompletedStudy of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive AssistanceThis study aims to learn about the needs and feelings of women who are infertile. Being infertile means not being able to have a child without the help of a third party.NCT00581646·New York, New York

CompletedStudy of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International…NCT01250223·Chicago, Illinois and 50 others

CompletedPhase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin LymphomaR-CHOP with doxorubicin is the standard first line treatment of high grade non-Hodgkin's lymphoma.NCT01958996·Poitiers

UnknownWhole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of LymphomaWhole body diffusion-weighted imaging is a functional magnetic resonance imaging technique that characterizes tissue by probing changes in water diffusion secondary to differences…NCT01231269·Leuven, Vlaams-Brabant

UnknownA Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)The objective of this study is to evaluate the efficacy of TQ-B3525 in patients with relapsed / refractory follicular lymphoma.NCT04324879·Hefei, Anhui and 40 others

CompletedCognitive Stimulation in Daily Activities for People Living With Early to Middle Stage DementiaThe goal of this study is to test the effect of CS-ADL is on people living with early to middle stage dementia.NCT06147479·Galway, Connacht

PreviousPage 248 of 330Next